iMDx to Participate in Lake Street 10th Annual Best Ideas Growth “BIG10” Conference

NASHVILLE, Tenn., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced participation in the upcoming Lake Street Capital Markets 10 th Annual Best Ideas Growth “BIG10” Conference taking place September 10 th, 2026 in New York.

Event: Lake Street Capital Markets 10 th Annual Best Ideas Growth “BIG10” Conference

Who: Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James

Date: Thursday, September 10, 2026

Location: Metropolitan Club, New York City

Format: One-on-one meetings

Investors wishing to meet with IMDX management are encouraged to reach out to their Lake Street sales representative.

About Insight Molecular Diagnostics Inc.

Insight Molecular Diagnostics is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. Investors may visit https://investors.imdxinc.com/ for more information.

GraftAssureCore™, GraftAssureIQ™, GraftAssureDx™, VitaGraft™, GraftAssure™, DetermaIO™, and DetermaCNI™ are trademarks of Insight Molecular Diagnostics Inc.

Investor Contact:

Alexandra Grossman

LifeSci Advisors LLC

imdx@lifesciadvisors.com